Drug Trial Radar · NCT05836324
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
570
Planned (sponsor's estimate)
Start
Jul 24, 2023
Primary completion
May 3, 2029
Study completion May 3, 2029
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- May 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.
Conditions
- Solid Tumors
- Advanced Solid Tumors
- Metastatic Solid Tumors
Interventions
INCA33890Drug
INCA33890 will be administered at protocol defined dose.
bevacizumabDrug
Bevacizumab will be administered at protocol defined dose.
FOLFIRIDrug
FOLFIRI will be administered at protocol defined dose.
FOLFOXDrug
FOLFOX will be administered at protocol defined dose.
CetuximabDrug
Cetuximab will be administered at protocol defined dose.
ADG126Drug
ADG126 will be administered at protocol defined dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose Limiting Toxicities (DLTs)Time frame: Up to 28 days
- Treatment Emerging Adverse Events (TEAEs)Time frame: Up to 2 years
- TEAEs leading to dose modification or discontinuationTime frame: Up to 2 years
Locations
39 sites in 9 countries. Site status is shown where the registry gives one.
The Angeles Clinic and Research Institute
Los Angeles, California · Recruiting
Valkyrie Clinical Trials
Los Angeles, California · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
Cancer and Hematology Centers of Western Michigan-Start Midwest
Grand Rapids, Michigan · Recruiting
Hackensack University Medical Center
Hackensack, New Jersey · Recruiting
Nyu Langone Health - Long Island Hospital
Mineola, New York · Recruiting
Laura and Isaac Perlmutter Cancer Center
New York, New York · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Lifespan Cancer Research Institute
Providence, Rhode Island · Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas · Recruiting
South Texas Accelerated Research Therapeutics
San Antonio, Texas · Recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China · Not yet recruiting
Peking University People'S Hospital
Beijing, China · Not yet recruiting
The First Affiliated Hospital, Zhejiang University School of Medicine (Fahzu)
Hangzhou, China · Not yet recruiting
Rigshospitalet Uni of Hospital of Copenhagen
Copenhagen, Denmark · Recruiting
Herlev Og Gentofte Hospital
Herlev, Denmark · Recruiting
Odense University Hospital
Odense C, Denmark · Recruiting
Vejle Hospital
Vejle, Denmark · Recruiting
Centre Leon Berard
Lyon, France · Recruiting
Institut Gustave Roussy
Villejuif, France · Recruiting
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Italy · Recruiting
Irccs Istituto Clinico Humanitas
Rozzano, Italy · Recruiting
Centro Ricerche Cliniche Di Verona
Verona, Italy · Recruiting
Kansai Medical University Hospital
Hirakata, Japan · Recruiting
National Cancer Center Hospital
Tokyo, Japan · Recruiting
The Cancer Institute Hospital of Jfcr
Tokyo, Japan · Recruiting
Start Barcelona
Barcelona, Spain · Recruiting
Hospital General Universitario Vall D Hebron
Barcelona, Spain · Recruiting
Fundacion Jimenez Diaz University Hospital
Madrid, Spain · Recruiting
Hospital Universitario 12 de Octubre
Madrid, Spain · Recruiting
Centro Integral Oncologico Clara Campal
Madrid, Spain · Recruiting
Istituto Oncologico Della Svizzera Italiana
Bellinzona, Switzerland · Recruiting
Centre Hospitalier Universitaire Vaudois (Chuv)
Lausanne, Switzerland · Recruiting
Kantonsspital St. Gallen
Sankt Gallen, Switzerland · Recruiting
Cambridge University Hospitals Nhs Foundation Trust
Cambridge, United Kingdom · Recruiting
Guys and St Thomas Nhs Foundation Trust
London, United Kingdom · Recruiting
Imperial College Healthcare Nhs Trust - Hammersmith Hospital
London, United Kingdom · Recruiting
The Christie Nhs Foundation Trust Uk
Manchester, United Kingdom · Recruiting
Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust
Newcastle upon Tyne, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.